J. Delarge

522 total citations
20 papers, 464 citations indexed

About

J. Delarge is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, J. Delarge has authored 20 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 5 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in J. Delarge's work include Neuroscience and Neuropharmacology Research (3 papers), Chemical Reaction Mechanisms (3 papers) and Synthesis and biological activity (2 papers). J. Delarge is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Chemical Reaction Mechanisms (3 papers) and Synthesis and biological activity (2 papers). J. Delarge collaborates with scholars based in Belgium and France. J. Delarge's co-authors include Bernard Pirotte, Jean‐Michel Dogné, Xavier de Leval, Fabien Julémont, Pascal De Tullio, E. Chleide, Jacques Bruhwyler, J. Damas, Jean‐François Denef and P Benoît and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

J. Delarge

19 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Delarge Belgium 11 173 168 119 81 58 20 464
Buichi Fujitani Japan 14 117 0.7× 224 1.3× 103 0.9× 75 0.9× 69 1.2× 46 649
Hans Petersen Denmark 11 121 0.7× 231 1.4× 47 0.4× 136 1.7× 67 1.2× 14 471
William T. McElroy United States 18 299 1.7× 191 1.1× 96 0.8× 24 0.3× 61 1.1× 25 703
Sadahiko Iguchi Japan 12 338 2.0× 191 1.1× 150 1.3× 42 0.5× 121 2.1× 20 707
Justin Ansell United States 11 133 0.8× 190 1.1× 65 0.5× 73 0.9× 114 2.0× 14 486
Karl Romstedt United States 12 113 0.7× 202 1.2× 120 1.0× 40 0.5× 41 0.7× 34 462
Jung‐Hui Sun United States 7 263 1.5× 199 1.2× 144 1.2× 149 1.8× 92 1.6× 12 664
Donald G. Gardiner United Kingdom 13 182 1.1× 269 1.6× 56 0.5× 62 0.8× 244 4.2× 21 735
D.L. Venton United States 14 109 0.6× 219 1.3× 246 2.1× 48 0.6× 163 2.8× 38 672
Giancarlo Bruni Italy 13 267 1.5× 239 1.4× 48 0.4× 91 1.1× 49 0.8× 33 649

Countries citing papers authored by J. Delarge

Since Specialization
Citations

This map shows the geographic impact of J. Delarge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Delarge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Delarge more than expected).

Fields of papers citing papers by J. Delarge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Delarge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Delarge. The network helps show where J. Delarge may publish in the future.

Co-authorship network of co-authors of J. Delarge

This figure shows the co-authorship network connecting the top 25 collaborators of J. Delarge. A scholar is included among the top collaborators of J. Delarge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Delarge. J. Delarge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dogné, Jean‐Michel, Xavier de Leval, P Benoît, et al.. (2002). Recent Advances in Antiplatelet Agents. Current Medicinal Chemistry. 9(5). 577–589. 45 indexed citations
2.
Leval, Xavier de, Fabien Julémont, J. Delarge, Bernard Pirotte, & Jean‐Michel Dogné. (2002). New Trends in Dual 5-LOX / COX Inhibition. Current Medicinal Chemistry. 9(9). 941–962. 102 indexed citations
3.
Tullio, Pascal De, J. Delarge, & Bernard Pirotte. (2000). Therapeutic and chemical developments of cholecystokinin receptor ligands. Expert Opinion on Investigational Drugs. 9(1). 129–146. 39 indexed citations
4.
5.
Khelili, Smaïl, et al.. (1999). Synthesis and Pharmacological Evaluation of K<SUB>ATP</SUB>-channel Openers Related to Cromakalim: Introduction of Arylsulphonylurea Moieties. Pharmacy and Pharmacology Communications. 5(3). 189–193. 8 indexed citations
6.
Khelili, Smaïl, Quỳnh Anh Nguyễn, P. Lebrun, J. Delarge, & Bernard Pirotte. (1998). Synthesis and pharmacological evaluation of ATP-sensitive potassium channel openers related to cromakalim: introduction of arylsulfonylurea or benzothiadiazinedioxide moieties. Open Repository and Bibliography (University of Liège). 1 indexed citations
7.
Scuvée‐Moreau, Jacqueline, A Dresse, Vincent Seutin, et al.. (1997). EFFECT OF POTASSIUM CHANNEL OPERATORS ON THE FIRING RATE OF HIPOCAMPAL PYRAMIDAL CELLS AND A10 DOPAMINERGIC NEURONSin vitro. Archives of Physiology and Biochemistry. 105(5). 421–428. 4 indexed citations
8.
Lebrun, Pierre, R. Ouedraogo, Cheikhou Kane, et al.. (1996). Activation of ATP-dependent K+ channels and inhibition of insulin release: effect of BPDZ 62.. Journal of Pharmacology and Experimental Therapeutics. 277(1). 156–162. 28 indexed citations
9.
Bruhwyler, Jacques, et al.. (1994). Pyridobenzoxazepine and Pyridobenzothiazepine Derivatives as Potential Central Nervous System Agents: Synthesis and Neurochemical Study. Journal of Medicinal Chemistry. 37(4). 519–525. 81 indexed citations
10.
Bruhwyler, Jacques, et al.. (1993). New pyridobenzodiazepine derivatives as potential antipsychotics: synthesis and neurochemical study. Journal of Medicinal Chemistry. 36(15). 2107–2114. 42 indexed citations
11.
Dupont, L., et al.. (1993). Comparative structural and stereoelectronical study of pinicadil, diazoxide and cromakalim, potassium channel openers belonging to three different chemical classes. Acta Crystallographica Section A Foundations of Crystallography. 49(s1). c149–c150.
12.
Masereel, Bernard, et al.. (1992). Na+,2Cl−,K+ cotransport system as a marker of antihypertensive activity of new torasemide derivatives. European Journal of Pharmacology. 219(3-4). 385–394. 8 indexed citations
13.
Dupont, Laurent, et al.. (1991). Structures du cyclohexyl-1 [(cycloheptylamino-4 pyridyl-3)sulfonyl]-3 urée et de l'hydrogénonitrate du cyclohexyl-1 [(cyclooctylamino-4 pyridyl-3)sulfonyl]-3 urée. Acta Crystallographica Section C Crystal Structure Communications. 47(10). 2152–2156. 3 indexed citations
14.
Delarge, J., et al.. (1988). [Attempt at determining the fragmentary constant (f) of the sulfonylurea groups].. PubMed. 43(3). 141–51. 1 indexed citations
15.
Dupont, L., et al.. (1987). Structure de l`acide diphénylamino-2-carboxylique. Acta Crystallographica Section C Crystal Structure Communications. 43(5). 926–928. 13 indexed citations
16.
Denef, Jean‐François, et al.. (1985). Renal effects of the high ceiling diuretic torasemide in rats and dogs.. PubMed. 35(10). 1527–31. 21 indexed citations
17.
Denef, Jean‐François, et al.. (1985). Pharmacological properties of the new potent diuretic torasemide in rats and dogs.. PubMed. 35(10). 1520–6. 38 indexed citations
18.
Delarge, J., et al.. (1984). [The effect of various 2-phenylamino-3-pyridine carbamoylsulfonamides on blood lipids].. PubMed. 38(6). 293–7. 1 indexed citations
19.
Delarge, J., et al.. (1981). [Some derivatives of gallosemide having diuretic properties in animals (author's transl)].. PubMed. 39(1). 59–63. 1 indexed citations
20.
Delarge, J., et al.. (1978). [A new class of high ceiling diuretics : derivatives of 1-alkyl-3-(4-phenylaminopyridin-3-yl)sulfonylurea (author's transl)].. PubMed. 36(7-8). 369–79. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Buichi Fujitani Breakdown of academic impact, for papers by Hans Petersen Breakdown of academic impact, for papers by William T. McElroy Breakdown of academic impact, for papers by Sadahiko Iguchi Breakdown of academic impact, for papers by Justin Ansell Breakdown of academic impact, for papers by Karl Romstedt Breakdown of academic impact, for papers by Jung‐Hui Sun Breakdown of academic impact, for papers by Donald G. Gardiner Breakdown of academic impact, for papers by D.L. Venton Breakdown of academic impact, for papers by Giancarlo Bruni
Rankless by CCL
2026